Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 5,808 | 8,188 | 9,435 | 9,889 | 9,141 |
| Operating Income | -5,808 | -8,188 | -9,435 | -9,889 | -9,141 |
| Interest Expense | 40 | 0 | 0 | 0 | 0 |
| Other Income | -214 | -529 | -1,604 | -352 | 58 |
| Pre-tax Income | -6,062 | -8,717 | -11,039 | -10,241 | -9,083 |
| Net Income Continuous | -6,062 | -8,717 | -11,039 | -10,241 | -9,083 |
| Net Income | $-6,062 | $-8,717 | $-11,039 | $-10,241 | $-9,083 |
| EPS Basic Total Ops | -0.74 | -1.21 | -1.66 | -1.40 | -1.40 |
| EPS Basic Continuous Ops | -0.74 | -1.19 | -1.66 | -1.50 | -1.37 |
| EPS Diluted Total Ops | -0.74 | -1.21 | -1.66 | -1.40 | -1.40 |
| EPS Diluted Continuous Ops | -0.74 | -1.19 | -1.66 | -1.50 | -1.37 |
| EBITDA(a) | $-5,806 | $-8,187 | $-9,434 | $-9,888 | $-9,140 |